 |
 |
 |
 |
 |
|
|
Contact | Print version | PDF version | Recommend company
|
Linnégatan 89 B 115 23 Stockholm
Sweden
|
|
Portrait Diamyd Medical is a life science company developing treatments for diabetes and its complications. The company’s furthest developed project is the GAD-based drug Diamyd® for autoimmune diabetes for which Phase III studies are planned. Diamyd® has demonstrated significant and positive results in Phase II clinical trials in Sweden.
Industrial Sectors
Additional information
Diamyd Medical AB Stockholm, Sweden
News
|
|
|
|
|
|